Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Cancer Medicine|December 1, 2025
Second Primary Cancer After Bladder Cancer: A Comprehensive Analysis of a National Cancer RegistryTomas Buchler, Lucie Pehalova Kusova, Alina Pirshtuk, et al.
Cancers|November 27, 2019
Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 PatientsOndrej Fiala, Pavel Ostasov, Ondrej Sorejs, et al.
Medical Oncology (Northwood, London, England)|July 4, 2012
Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinomaTomas Buchler, Tomas Pavlik, Zbynek Bortlicek, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 1, 2014
Glycogen phosphorylase BB levels are associated with haemodynamic parameters in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt insertionMartina Vasatova, Radek Pudil, Tomas Buchler, et al.
Annals of Clinical Biochemistry|February 23, 2013
Elevated cardiac markers are associated with higher mortality in patients after transjugular intrahepatic portosystemic shunt insertionMartina Vasatova, Radek Pudil, Vaclav Safka, et al.
Frontiers in Oncology|August 19, 2022
TElomeric repeat-containing RNA (TERRA): Physiological functions and relevance in cancerMichal Kroupa, Kristyna Tomasova, Miriam Kavec, et al.
Anticancer Research|February 11, 2014
Efficacy and toxicity of bevacizumab on combination with chemotherapy in different lines of treatment for metastatic colorectal carcinomaIgor Kiss, Zbynek Bortlicek, Bohuslav Melichar, et al.
Anticancer Research|May 2, 2018
Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor ResponseJulia Kovacova, Jaroslav Juracek, Alexandr Poprach, et al.
Cancers|March 25, 2022
Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data AnalysisLola-Jade Palmieri, Tomas Buchler, Antoine Meyer, et al.
Biochemia Medica|July 12, 2017
Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinomaMichal Fedorko, Jaroslav Juracek, Michal Stanik, et al.
Pageof 14